Venture capital firm Mountain Group Partners (Mountain Group) has closed the its third fund, MGP Venture Fund III (MGP Fund III), above target at $128 million. Mountain Group will continue its strategy of investing in early-stage companies within human and animal life sciences and disruptive technologies. MGP Fund III has already made five investments including two in the fast-growing animal health sector. In May 2022, the Firm partnered with Merck Animal Health and NovaQuest Capital Management in co-leading a $35 million Series C financing for Targan.  Another primary focus for MGP Fund III will be in diagnostics, a sector in

Seed-stage venture capital firm True Wealth Ventures has held the close of its oversubscribed Fund II with $35 million in capital commitments. The seed-stage VC firm focuses on maximizing the number of women in its funds to invest in women-led companies. Fund II’s close follows True Wealth Ventures’ 2018 $19.1 million Fund I close — the largest venture capital fund ever raised at that time with an explicit gender-diversity strategy. Fund I’s 80% women limited partners was unprecedented. True Wealth’s total AUM is now about $60 million. Founding General Partner Sara Brand and General Partner Kerry Rupp lead True Wealth

Twin Bridge Capital Partners (Twin Bridge) a private equity firm that targets investments in the North American small and lower middle market, has closed its fifth flagship lower middle market fund, Pacific Street Fund V, with more than $880 million in capital commitments. Fund V was oversubscribed and exceeded its $800 million target. Twin Bridge has raised over $3.9 billion in capital and has invested in more than 200 funds and co-investments since the firm’s inception in 2005. Fund V will continue to invest in a diversified mix of top performing lower middle market buyout funds targeting between $400 million

Illumina, a specialist in DNA sequencing and array-based technologies, has invested in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in both San Francisco and Cambridge, is a company creation engine that partners with entrepreneurs to create genomics startups and advance innovative applications. Illumina joins a select group of US and European investors in the life sciences fund, including cornerstone investor LifeArc. Time Boost Capital’s £30 million in capital commitments from select US

Plural, a new investment platform started by the founders and backers of some of Europe’s most significant tech companies, has launched, along with a €250 million early stage venture fund to back the next generation of founders with global ambitions.

MaC Venture Capital, a seed-stage venture capital firm based in Los Angeles and Silicon Valley, has successfully raised a $203 million Fund II, building on the $110 million seed-stage fund secured in March 2021. MaC Venture Capital, a majority Black-owned firm, will use Fund II capital to double down on their cultural investment framework, which has successfully supported technology startups who are shaping culture, increasing access and resources to underserved communities, and meeting consumer and industry needs. The four founding general partners include seasoned operator and venture capitalist Marlon Nichols; former Washington, DC Mayor Adrian Fenty; former William Morris Agency

Minority-owned, emerging real estate investment manager, Brasa Capital Management LLC (Brasa), has successfully closed Brasa Real Estate Fund II (Fund II), at its hard cap of $450 million. With an original target of $300 million, Brasa has now exceeded its fundraising goal on its first two discretionary investment vehicles. In May 2019, only a year after its founding, Brasa closed Brasa Real Estate Fund (Fund I) in excess of its $100 million fundraising goal with $120 million in capital commitments.    Founded in 2018, Brasa Capital focuses on middle-market, real estate opportunities throughout the Western United States and Texas. Brasa

Heligan Group has closed its debut fundraise for its Heligan Investments business. The Heligan Private Equity I fund will mainly target buyout investments (but will also consider minority investments on a case-by-case basis) in high growth technology companies with enterprise values between £5 million and £50 million and with a focus on the National Security, Crime Prevention and Public Safety sectors.  Heligan’s Partner led team is supported by a global network of distinguished professionals from the technology, law enforcement, military and intelligence fields, adding an invaluable layer of insight and influence. Shoosmiths (Ben Turner, Barry Stimpson and Siffat Khan) advised

New York City-based venture capital firm Vine Ventures has closed its second fund, Fund II, with total commitments of $140 million from a raft of investors including Tiger Global Management, Goldman Sachs, General Atlantic, and Blackstone, according to a report by CTech. The founders of Carta, Shutterstock, and Hippo are also all among the investors in the new fund which will focus on investments of between $1 million and $10 million in B2B companies in the cloud, cybersecurity, AI, data, and fintech sectors. Fundraising for Fund II brings Vine Ventures’ total AUM to $243 million. 

Brookfield Asset Management has closed its Brookfield Global Transition Fund (BGTF) with $15 billion in capital commitments, making it one of the largest funds raised with a focus on facilitating the global transition to a net-zero carbon economy. The $15 billion includes investments from institutional investors in and alongside the fund, as well as amounts reserved for the private wealth channel. Highlighting strong industry support for decarbonisation, demand for the fund significantly exceeded its initial hard cap, and the final fund size was oversubscribed. A diverse group of more than 100 investors from around the world committed to the Fund,